Ftse Mib
34.396,13
0,24%
DAX
20.242,57
-0,05%
S&P 500
6.060,26
0,16%
NASDAQ
20.154,97
0,23%
Bitcoin
104.670,99
-1,39%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Longeveron Inc (LGVN) Longeveron Inc (LGVN) Notizie

Longeveron Inc

LGVN
1,7599
-0,0201 (-1,13%)
Ultimo aggiornamento: 19:13:34
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202415:10GLOBELongeveron to Present at Biotech Showcase 2025
12/11/202422:12EDGAR2Form 8-K - Current report
12/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:05GLOBELongeveron® Announces Third Quarter 2024 Financial Results..
11/11/202415:05GLOBELongeveron® Appoints Devin Blass as Chief Technology Officer..
04/11/202422:05GLOBELongeveron® to Report Third Quarter 2024 Financial Results..
29/10/202415:00GLOBELongeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease..
27/10/202420:10GLOBELongeveron® Presents Lomecel-B™ Long-term Transplant-free..
14/10/202415:05GLOBELongeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected..
09/10/202415:05GLOBELongeveron® Lomecel-B™ 5-Year Long-term Transplant-free..
07/10/202415:05GLOBELongeveron® to Present at the UBS Virtual Organ Restoration..
04/10/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202415:05GLOBELongeveron® to Participate in the 3rd Annual ROTH Healthcare..
26/9/202415:05GLOBELongeveron to Attend Alliance for Regenerative Medicine’s..
03/9/202415:00GLOBELongeveron® Announces Positive Type C Meeting with U.S. FDA..
26/8/202422:05GLOBELongeveron to Present at the H.C. Wainwright 26th Annual..
15/8/202412:08IHMARKETNEWSCisco Beats Estimates and Announces Restructuring, Canoo..
14/8/202422:05GLOBELongeveron® Announces Second Quarter 2024 Financial Results..
14/8/202411:58IHMARKETNEWSU.S. Futures Steady After Tuesday’s Strong Recovery; CPI in..
05/8/202422:05GLOBELongeveron® to Report Second Quarter 2024 Financial Results..
28/7/202422:51GLOBELongeveron® Presents Study Results from CLEAR MIND Phase 2a..
19/7/202422:05GLOBELongeveron Announces Closing of $9.0 Million Registered..
18/7/202414:45GLOBELongeveron Announces $9.0 Million Registered Direct Offering..
17/7/202414:00GLOBELongeveron® Announces U.S. FDA Grants Fast Track Designation..
10/7/202413:30GLOBELongeveron® Announces U.S. FDA Grants..
09/7/202415:00GLOBENeha Motwani Elected to Longeveron® Board of Directors
08/7/202415:00GLOBEGene Therapy Pioneer Roger Hajjar, MD, Elected to..
21/6/202414:35GLOBELife Science Virtual Investor Forum Presentations Now..
18/6/202422:48GLOBELongeveron Raises $4.4 Million in Gross Proceeds from..
17/6/202415:00GLOBELongeveron® to Present at the Virtual Life Sciences Investor..
17/6/202414:38GLOBELongeveron Announces Exercise of Warrants for $4.4 Million..
11/6/202415:00GLOBELongeveron® Announces Completion of Successful Investigator..
03/6/202415:00GLOBELongeveron® Announces Contract Development and Manufacturing..
28/5/202414:05GLOBELongeveron® to Attend BIO International Convention 2024
14/5/202422:05GLOBELongeveron Announces First Quarter 2024 Financial Results..
10/5/202422:05GLOBELongeveron Announces Board of Directors Planned Transitions
02/5/202414:03GLOBELongeveron to Report First Quarter 2024 Financial Results..
25/4/202422:05GLOBELongeveron to Present at the Planet MicroCap Showcase
18/4/202422:05GLOBELongeveron Raises a Total of $11.4 Million in Gross Proceeds..
17/4/202414:00GLOBELongeveron Announces Exercise of Warrants for $6.2 Million..
15/4/202414:30GLOBELongeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial..
11/4/202423:17GLOBELongeveron Announces Closing of $5.2 Million Public Offering
08/4/202420:15GLOBELongeveron Announces Pricing of $5.25 Million Public..
08/4/202414:30GLOBELongeveron Issues Letter to Shareholders Highlighting..
Apertura: 1,78 Min: 1,71 Max: 1,80
Chiusura: 1,78

La tua Cronologia

NASDAQ
LGVN
Longeveron
NASDAQ
NWSA
News
LSE
ZG22
Rep.colombia 36
COIN
GLCGBP
GoldCoin
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network